Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


20 Mart 2022, Pazar, 16:02 Haber Kaynağı: Çeşitli Haber Siteleri
Çip krizinde yeni kriz: Neon gazı ve paladyum sıkıntısı
Covid-19 salgınının ardından patlayan Rusya- Ukrayna savaşının neden olduğu küresel tedarik zincirindeki bozulmalar devam ediyor. Son olarak yarı iletken çip üretiminde önemli yeri olan neon gazı ve paladyum gibi maddelerin üretiminde sıkıntı yaşandığı açıklandı.
https://www.cumhuriyet.com.tr/ekonomi/cip-krizinde-yeni-kriz-neon-gazi-ve-paladyum-sikintisi-1917721

20 Mart 2022, Pazar, 15:32 Haber Kaynağı: Çeşitli Haber Siteleri
Covid-19’da felaketi yaşıyorlar: Hastalar, yaşamını yitirenlerle aynı yerde kalıyor
Hong Kong’ta Covid-19 felaketi tekrar başladı… İki yıl önce Avrupa ve ABD corona virüsü salgınıyla kapanırken, çok sıkı önlemler alan ve uluslararası kamuoyu tarafından takdir toplayan Hong Kong’ta corona virüsü salgını yeniden patlak verdi… Hong Kong’ta son haftalarda vaka ve ölüm sayısı hızla artarken, son 24 saatte 14.149 insanda Covid-19 tespit edilirken 246 insan da […]
https://www.sozcu.com.tr/2022/saglik/covid-19da-felaketi-yasiyorlar-hastalar-coronadan-olenlerle-ayni-yerde-kaliyor-7022935/

20 Mart 2022, Pazar, 14:02 Haber Kaynağı: Çeşitli Haber Siteleri
Salgında son 24 saat: 17 bin 328 vaka; 105 can kaybı
Türkiye'de 17 bin 328 kişinin COVID-19 testi pozitif çıktı, 105 kişi hayatını kaybetti.
https://www.dunya.com/gundem/salginda-son-24-saat-17-bin-328-vaka-105-can-kaybi-haberi-652429

20 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022
This report describes adult COVID-19 hospitalization rates by race/ethnicity during SARS-CoV-2 Delta and Omicron predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=625715

20 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022
This report describes effectiveness of mRNA COVID-19 vaccination in preventing COVID-19 associated invasive mechanical ventilation and death after receiving 2 or 3 vaccine doses.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=625714

20 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022
This report describes the Advisory Committee on Immunization Practices' recommendation for use of the Moderna COVID-19 vaccine in adults.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=622515

20 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
Hospitalization of Infants and Children Aged 0-4 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022
This report describes COVID-19 hospitalization rates among infants and children aged 0-4 years, including during Omicron variant predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=613117

20 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022
This report describes COVID-19 vaccine provider access and vaccination coverage among U.S. children aged 5-11 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=600326

20 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022
This report describes mRNA COVID-19 vaccine effectiveness in preventing emergency department and urgent care encounters as well as hospitalizations among children and adolescents.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=575259

20 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022
This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=575231